Rituxan don MS

Wadatacce

• Game da amfani da lakabin lakabi
• Shin Rituxan yana da lafiya da inganci don kula da MS?
• Shin yana da tasiri?
• Lafiya kuwa?
• Menene bambanci tsakanin Rituxan da Ocrevus?
• Takeaway

Bayani

Rituxan (sunan mai suna rituximab) magani ne na takardar sayan magani wanda ke nufin furotin da ake kira CD20 a cikin ƙwayoyin garkuwar B. Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da shi don magance cututtuka irin su lymphoma na Non-Hodgkin da rheumatoid arthritis (RA).

Wasu lokuta likitoci sukan rubuta Rituxan don magance cututtukan ƙwayar cuta mai yawa (MS), kodayake FDA ba ta yarda da shi don wannan amfani ba. Ana kiran wannan azaman amfani da "kashe-lakabin" magani.

Game da amfani da lakabin lakabi

Amfani da lakabin-lakabin amfani yana nufin cewa magani wanda FDA ta yarda dashi don manufa ɗaya ana amfani dashi don wata manufa daban wacce ba a yarda da ita ba.

Koyaya, likita har yanzu yana iya amfani da miyagun ƙwayoyi don wannan dalili. Wannan saboda FDA ta tsara gwajin da yarda da magunguna, amma ba yadda likitoci ke amfani da kwayoyi don kula da marasa lafiya ba. Don haka likitanku na iya ba da umarnin magani duk da haka suna ganin shine mafi kyau don kulawa. Ara koyo game da amfani da lakabin magani ba tare da lakabi ba.

Idan likitanku ya tsara muku magani don amfani da lakabin lakabi, ya kamata ku ji daɗin tambayar duk tambayoyin da kuke da su. Kana da damar shiga cikin duk wata shawara game da kulawarka.

Misalan tambayoyin da zaku iya yi sun haɗa da:

• Me yasa kuka ba da umarnin amfani da lakabin wannan magani?
• Shin akwai wasu magungunan da aka yarda da su waɗanda zasu iya yin abu ɗaya?
• Shin inshorar lafiyata za ta rufe wannan amfani da magani?
• Shin kun san irin tasirin da zan iya samu daga wannan magani?

Shin Rituxan yana da lafiya da inganci don kula da MS?

Babu wata yarjejeniya a kan daidai yadda aminci da tasirin Rituxan don magance MS, amma karatu yana nuna cewa yana nuna alƙawari.

Shin yana da tasiri?

Kodayake ba a sami isasshen kwatancen ainihin tasirin tasirin duniya don yanke hukunci a kan Rituxan azaman magani mai tasiri ga MS, alamu masu kyau suna nuna yana iya zama.

Nazarin rajista na Sweden na Sweden ya kwatanta Rituxan tare da cututtukan farko na gargajiya wanda ke canza zaɓin magani kamar su

• Tecfidera (dimethyl fumarate)
• Gilenya (fingolimod)
• Tysabri (natalizumab)

Dangane da dakatar da miyagun ƙwayoyi da ingancin asibiti a sake dawowa-sake ƙaddamar da ƙwayar cuta mai yawa (RRMS), Rituxan ba wai kawai shine zaɓin jagora don jiyya na farko ba, har ma ya nuna kyakkyawan sakamako.

Lafiya kuwa?

Rituxan yana aiki azaman wakili mai lalata kwayar B. A cewar, rashi tsawon lokaci na kwayoyin B na gefe ta hanyar Rituxan ya bayyana lafiya, amma ana bukatar karin nazari.

Illolin Rituxan na iya haɗawa da:

• halayen jiko kamar kurji, kaikayi, da kumburi
• matsalolin zuciya irin su bugun zuciya mara tsari
• matsalolin koda
• zubar da gumis
• ciwon ciki
• zazzaɓi
• jin sanyi
• cututtuka
• ciwon jiki
• tashin zuciya
• kurji
• gajiya
• ƙananan ƙwayoyin jini
• matsalar bacci
• kumbura harshe

Bayanan lafiya na sauran jiyya kamar su Gilenya da Tysabri na mutanen da ke tare da MS suna da takardu da yawa fiye da Rituxan.

Menene bambanci tsakanin Rituxan da Ocrevus?

Ocrevus (ocrelizumab) magani ne wanda aka yarda dashi na FDA wanda ake amfani dashi don maganin RRMS da ƙananan ƙwayoyin cuta na farko (PPMS).

Wasu mutane sunyi imanin cewa Ocrevus shine kawai sake fasalin Rituxan. Dukansu suna aiki ne ta hanyar amfani da ƙwayoyin B tare da ƙwayoyin CD20 a saman su.

Genentech - wanda ya kirkiro magungunan biyu - ya bayyana cewa akwai bambance-bambancen kwayoyin kuma kwayoyi kowannensu yana hulda da tsarin garkuwar jiki daban.

Babban bambanci shine cewa ƙarin shirye-shiryen inshorar lafiya sun rufe Ocrevus don maganin MS fiye da Rituxan.

Takeaway

Idan ku - ko wani na kusa da ku - kuna da MS kuma kuna jin cewa Rituxan na iya zama wani zaɓi na magani daban, tattauna wannan zaɓin tare da likitanku. Likitanku na iya ba da hankali game da jiyya iri-iri da yadda za su yi aiki don yanayinku na musamman.